Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2020 / Articles / Jun / Branching Out
Discovery & Development Drug Discovery Research News

Branching Out

Energy-saving hardware could reduce the carbon footprint of AI-driven drug development

By Maryam Mahdi 06/20/2020 0 min read Quick Read (pre 2022)

Share

From aiding in the development of new drugs to enhancing the efficiency of manufacturing practices, AI is changing the way pharma works. But AI’s impact on the environment has not yet been fully addressed – it’s estimated that the energy consumed by computers when training an AI platform results in a carbon footprint that is five times greater than the entire lifespan of a car (1).

Now, researchers at Purdue University have developed a hardware device made of quantum material that could inject extra intelligence, reducing reliance on energy-draining software platforms (2). According to Shriram Ramanathan, a professor at the university, the hardware’s design was inspired by the way the human brain stores and recalls information.

“Human beings store elementary information in a hierarchical way in their brains. And this allows us to categorize complex information so that it can be recalled and reconstructed when needed,” he explains. “Similarly our device relies on neural trees whose ‘branches’ hold information about different categories of data.”

In brief, the researchers introduced a proton to neodymium nickel oxide – a quantum material – and applied an electric pulse to the proton, causing it to move through the material and create areas of electrical resistance that behave like data storage sites.

Ramanathan believes the device could eventually be of benefit to pharma, which will increasingly rely on AI. “Companies often deal with large and complex datasets. Using our hardware, patient, drug, and disease information could be sorted into various categories allowing patterns to be easily identified across datasets,” he says. Understanding such patterns could help researchers extract the most meaningful information from their records and develop drugs best suited to specific disease areas.”

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. MIT, “Reducing the carbon footprint of artificial intelligence”, (2020). Available at: https://bit.ly/2zNMz2k 
  2. H Zhang et al., “Perovskite neural trees”, Nature Communications, 11, 2245 (2020).

About the Author(s)

Maryam Mahdi

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

More Articles by Maryam Mahdi

False

Advertisement

Recommended

False

Related Content

Understanding the H5N1 Threat
Vaccines Drug Discovery
Understanding the H5N1 Threat

February 3, 2025

4 min read

With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?

Battle of the Superbugs
Drug Discovery Technology and Equipment
Battle of the Superbugs

December 1, 2014

0 min read

Can phage endolysins revolutionize the way bacterial infections are treated – and prevent drug resistance?

Antibiotics: Going With the Flow
Drug Discovery Small Molecules
Antibiotics: Going With the Flow

April 2, 2025

2 min read

How fluid flow through the body can affect the ways in which antibiotics work.

Combatting the Side Effects of Treatments for Parkinson’s
Drug Discovery Small Molecules
Combatting the Side Effects of Treatments for Parkinson’s

April 7, 2025

4 min read

Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.